Understanding Your Laboratory Test: What It Is, Why It Is Done, and What Your Results Mean
This test detects IgA antibodies against Borrelia burgdorferi (Lyme disease bacteria) in cerebrospinal fluid to help diagnose nervous system Lyme disease.
{"The test uses cerebrospinal fluid (CSF) collected via lumbar puncture to detect IgA antibodies against Lyme disease bacteria","A positive result suggests Lyme disease has spread to the central nervous system (neuroborreliosis)","This test is specifically used when neurological symptoms like meningitis, facial palsy, or nerve pain occur after a possible Lyme disease exposure","Results should be interpreted alongside clinical symptoms, other test results, and exposure history"}
Key facts at a glance
- LOINC
- 109447-3
- Short code
- BBURGIA
- Synonyms
- B burgdor IgA Msmt CSF
- Category
- chemistry
- Sample
- csf
- Container
- Sterile CSF collection tube (polypropylene)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Enzyme Immunoassay (EIA)
- CPT
- 86618
- SNOMED
- 39517005
- Specimen volume
- 1-2 mL of cerebrospinal fluid
- Stability
- Room temperature: 2 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days
- Hemolysis max
- 200
- TAT
- 24–72 hours
- Order
- routine
This test is a laboratory analysis performed on a sample of your blood, urine, or other body fluid. It helps your doctor evaluate how well your body is functioning and look for signs of illness, infection, or other health conditions that may need further attention or treatment.
The Borrelia burgdorferi IgA Antibody test detects IgA-class antibodies in cerebrospinal fluid (CSF) that your immune system produces in response to infection with Borrelia burgdorferi, the bacterium that causes Lyme disease. This specific test looks for IgA antibodies, which are one of the first types of antibodies your body makes when fighting an infection and are found in mucus membranes and body fluids.
Your doctor may order this test to help diagnose a medical condition, monitor an illness you already have, check how well a treatment is working, or screen for potential health problems before symptoms appear, so that any needed care can begin as early as possible.
This test is performed when a patient has neurological symptoms that may indicate Lyme disease has spread to the nervous system, a condition called neuroborreliosis. Symptoms that might warrant this test include severe headache, neck stiffness, facial drooping (facial palsy), numbness or tingling in extremities, limb weakness, and pain radiating from the spine. It is typically ordered when there is a suspicion of Lyme disease affecting the brain or spinal cord.
A trained healthcare professional will collect the sample, most often by drawing a small amount of blood from a vein in your arm using a thin, sterile needle. The procedure usually takes only a few minutes, and you may feel a quick pinch or slight pressure at the site.
Cerebrospinal fluid is collected through a procedure called a lumbar puncture (spinal tap). During this procedure, a healthcare provider inserts a thin needle between the bones in your lower back to withdraw a small amount of CSF. The area is numbed with local anesthetic to minimize discomfort. The CSF sample is then sent to a laboratory for analysis.
Your results are compared with established reference ranges, and your doctor will interpret them together with your symptoms, medical history, and other test findings before discussing what they mean, whether any follow-up testing is needed, and what the next steps in your care should be.
Results are typically reported as positive or negative. A positive result means IgA antibodies against Borrelia burgdorferi were detected in your CSF, indicating that the Lyme disease bacterium has likely spread to your central nervous system. A negative result means no antibodies were detected, but this does not completely rule out Lyme disease, especially if the infection is very early or your immune system has not yet produced detectable levels of antibodies. Your healthcare provider will interpret these results together with your symptoms, medical history, and possibly other test results.
Reference range
Negative (antibody not detected)N/A
No special preparation required. Lumbar puncture performed by qualified healthcare provider under sterile conditions.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Detection of Borrelia burgdorferi-specific IgA antibodies in CSF is highly suggestive of neuroborreliosis, which occurs in approximately 10-15% of untreated Lyme disease cases. This test helps confirm that the Lyme disease bacterium has crossed the blood-brain barrier and is affecting the central nervous system. A positive result supports the diagnosis of neurological Lyme disease, which requires specific antibiotic treatment, often with intravenous antibiotics rather than oral medications. This test is particularly valuable because it demonstrates the presence of an active immune response specifically within the central nervous system, rather than just in the blood.
Frequently asked questions
Is a lumbar puncture painful?
How long does it take to get results?
Can this test diagnose Lyme disease on its own?
What happens if the test is positive?
Do I need to fast before this test?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy